CellAct Pharma GmbH

IN VITRO DIAGNOSTICS Financings Cancer Genetics Inc. Molecular diagnostics firm Cancer Genetics Inc. entered a financing agreement with Aspire Capital, through which Aspire will purchase, over the

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal i

Mundipharma International Corp. Ltd. has acquired from Germany-based CellAct Pharma GMBH worldwide development, commercialization and manufacturing rights to "smart" chemotherapy agent CAP7-1 –

New targets, novel mechanisms and partnering prospects spell opportunity for start-ups developing drugs for inflammatory-autoimmune diseases. The inflammatory cascade linked to autoimmune disorders li